169 related articles for article (PubMed ID: 17592745)
1. Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.
Mougin-Degraef M; Bourdeau C; Jestin E; Saï-Maurel C; Bourgeois M; Saëc PR; Thédrez P; Gestin JF; Barbet J; Faivre-Chauvet A
Int J Pharm; 2007 Nov; 344(1-2):110-7. PubMed ID: 17592745
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy.
Jestin E; Mougin-Degraef M; Faivre-Chauvet A; Remaud-Le Saëc P; Hindre F; Benoit JP; Chatal JF; Barbet J; Gestin JF
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):51-60. PubMed ID: 17372573
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals.
Helbok A; Decristoforo C; Dobrozemsky G; Rangger C; Diederen E; Stark B; Prassl R; von Guggenberg E
J Liposome Res; 2010 Sep; 20(3):219-27. PubMed ID: 19863193
[TBL] [Abstract][Full Text] [Related]
4. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS
Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376
[TBL] [Abstract][Full Text] [Related]
6. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations.
Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC
Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464
[TBL] [Abstract][Full Text] [Related]
7. Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody.
Rauscher A; Frindel M; Maurel C; Maillasson M; Le Saëc P; Rajerison H; Gestin JF; Barbet J; Faivre-Chauvet A; Mougin-Degraef M
Nucl Med Biol; 2014 May; 41 Suppl():e66-74. PubMed ID: 24485990
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine.
Arulsudar N; Subramanian N; Mishra P; Sharma RK; Murthy RS
J Drug Target; 2003 Apr; 11(3):187-96. PubMed ID: 13129826
[TBL] [Abstract][Full Text] [Related]
9. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy.
Le UM; Cui Z
Int J Pharm; 2006 Apr; 312(1-2):105-12. PubMed ID: 16457973
[TBL] [Abstract][Full Text] [Related]
10. A simple and efficient method for radiolabeling of preformed liposomes.
Suresh M; Cao Y
J Pharm Pharm Sci; 1998; 1(1):31-7. PubMed ID: 10942970
[TBL] [Abstract][Full Text] [Related]
11. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of a DOTA-lysine-biotin conjugate as an effector molecule for pretargeted radionuclide therapy.
Hainsworth J; Harrison P; Mather SJ
Bioconjug Chem; 2005; 16(6):1468-74. PubMed ID: 16287243
[TBL] [Abstract][Full Text] [Related]
13. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
Dams ET; Laverman P; Oyen WJ; Storm G; Scherphof GL; van Der Meer JW; Corstens FH; Boerman OC
J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled liposomes as metabolic and scanning tracers in mice. II. In-111 oxine compared with Tc-99m DTPA, entrapped in multilamellar lipid vesicles.
Espinola LG; Beaucaire J; Gottschalk A; Caride VJ
J Nucl Med; 1979 May; 20(5):434-40. PubMed ID: 120420
[TBL] [Abstract][Full Text] [Related]
15. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS
Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109
[TBL] [Abstract][Full Text] [Related]
16. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
17. Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution.
Plassat V; Martina MS; Barratt G; Ménager C; Lesieur S
Int J Pharm; 2007 Nov; 344(1-2):118-27. PubMed ID: 17583452
[TBL] [Abstract][Full Text] [Related]
18. Radioiodination of glycoprotein-conjugated liposomes by using the Bolton-Hunter reagent and biodistribution in tumor-bearing mice.
Shimura N; Sogawa Y; Kawakita Y; Ikekita M; Yamazaki N; Kojima S
Nucl Med Biol; 2002 May; 29(4):491-6. PubMed ID: 12031885
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.
Duan Y; Wei L; Petryk J; Ruddy TD
Int J Nanomedicine; 2016; 11():5697-5708. PubMed ID: 27843312
[TBL] [Abstract][Full Text] [Related]
20. Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units.
Momekova D; Rangelov S; Yanev S; Nikolova E; Konstantinov S; Romberg B; Storm G; Lambov N
Eur J Pharm Sci; 2007 Dec; 32(4-5):308-17. PubMed ID: 17928206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
